A Prospective/Retrospective,Randomized Controlled Clinical Study of Interferon Atomization in the 2019-nCoV Pneumonia
Status:
Recruiting
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
At present, there is no specific and effective antiviral therapy.In this study, an open,
prospective/retrospective, randomized controlled cohort study was designed to compare the
efficacy of two therapeutic schemes(abidol hydrochloride,abidol hydrochloride combined with
interferon atomization)in the treatment of 2019-nCoV viral pneumonia, so as to provide
reliable evidence-based medicine for the treatment of viral pneumonia caused by 2019-nCoV.